Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
Cannabinoids are known to modulate oligodendrogenesis and developmental CNS myelination. However, the cell-autonomous action of these compounds on oligodendroglial cells in vivo, and the molecular mechanisms underlying these effects have not yet been studied. Here, by using oligodendroglial precurso...
| Autores: | , , , , , , , , , , , , |
|---|---|
| Tipo de documento: | artigo |
| Data de publicação: | 2022 |
| País: | España |
| Recursos: | Universidad Complutense de Madrid (UCM) |
| Repositório: | Docta Complutense |
| Idioma: | inglês |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/88941 |
| Acesso em linha: | https://hdl.handle.net/20.500.14352/88941 |
| Access Level: | Acceso aberto |
| Palavra-chave: | 615.9 591.18 612.8 Cannabinoid CB1 receptor Oligodendrogenesis Myelination Bioquímica (Biología) Biología molecular (Biología) Neurociencias (Biológicas) 2403 Bioquímica 2407 Biología Celular 2490 Neurociencias |
| id |
ES_b40a40173c71ff5a8e2b5eed1e7ba04d |
|---|---|
| oai_identifier_str |
oai:docta.ucm.es:20.500.14352/88941 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in miceSánchez De La Torre, AníbalAguado Sánchez, TaniaHuerga-Gómez, AlbaSantamaría, SilviaGentile, AntoniettaChara, Juan CarlosMatute, CarlosMonory, KrisztinaMato, SusanaGuzmán Pastor, ManuelLutz, BeatGalve Roperh, IsmaelPalazuelos Diego, Javier615.9591.18612.8Cannabinoid CB1 receptorOligodendrogenesisMyelinationBioquímica (Biología)Biología molecular (Biología)Neurociencias (Biológicas)2403 Bioquímica2407 Biología Celular2490 NeurocienciasCannabinoids are known to modulate oligodendrogenesis and developmental CNS myelination. However, the cell-autonomous action of these compounds on oligodendroglial cells in vivo, and the molecular mechanisms underlying these effects have not yet been studied. Here, by using oligodendroglial precursor cell (OPC)-targeted genetic mouse models, we show that cannabinoid CB1 receptors exert an essential role in modulating OPC differentiation at the critical periods of postnatal myelination. We found that selective genetic inactivation of CB1 receptors in OPCs in vivo perturbs oligodendrogenesis and postnatal myelination by altering the RhoA/ROCK signaling pathway, leading to hypomyelination, and motor and cognitive alterations in young adult mice. Conversely, pharmacological CB1 receptor activation, by inducing E3 ubiquitin ligase-dependent RhoA proteasomal degradation, promotes oligodendrocyte development and CNS myelination in OPCs, an effect that was not evident in OPC-specific CB1 receptordeficient mice. Moreover, pharmacological inactivation of ROCK in vivo overcomes the defects in oligodendrogenesis and CNS myelination, and behavioral alterations found in OPC-specific CB1 receptor-deficient mice. Overall, this study supports a cellautonomous role for CB1 receptors in modulating oligodendrogenesis in vivo, which may have a profound impact on the scientific knowledge and therapeutic manipulation of CNS myelination by cannabinoids.Springer NatureUniversidad Complutense de Madrid20222022-01-0120222022-01-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/88941reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/889412026-06-02T12:44:21Z |
| dc.title.none.fl_str_mv |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
| title |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
| spellingShingle |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice Sánchez De La Torre, Aníbal 615.9 591.18 612.8 Cannabinoid CB1 receptor Oligodendrogenesis Myelination Bioquímica (Biología) Biología molecular (Biología) Neurociencias (Biológicas) 2403 Bioquímica 2407 Biología Celular 2490 Neurociencias |
| title_short |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
| title_full |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
| title_fullStr |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
| title_full_unstemmed |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
| title_sort |
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice |
| dc.creator.none.fl_str_mv |
Sánchez De La Torre, Aníbal Aguado Sánchez, Tania Huerga-Gómez, Alba Santamaría, Silvia Gentile, Antonietta Chara, Juan Carlos Matute, Carlos Monory, Krisztina Mato, Susana Guzmán Pastor, Manuel Lutz, Beat Galve Roperh, Ismael Palazuelos Diego, Javier |
| author |
Sánchez De La Torre, Aníbal |
| author_facet |
Sánchez De La Torre, Aníbal Aguado Sánchez, Tania Huerga-Gómez, Alba Santamaría, Silvia Gentile, Antonietta Chara, Juan Carlos Matute, Carlos Monory, Krisztina Mato, Susana Guzmán Pastor, Manuel Lutz, Beat Galve Roperh, Ismael Palazuelos Diego, Javier |
| author_role |
author |
| author2 |
Aguado Sánchez, Tania Huerga-Gómez, Alba Santamaría, Silvia Gentile, Antonietta Chara, Juan Carlos Matute, Carlos Monory, Krisztina Mato, Susana Guzmán Pastor, Manuel Lutz, Beat Galve Roperh, Ismael Palazuelos Diego, Javier |
| author2_role |
author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universidad Complutense de Madrid |
| dc.subject.none.fl_str_mv |
615.9 591.18 612.8 Cannabinoid CB1 receptor Oligodendrogenesis Myelination Bioquímica (Biología) Biología molecular (Biología) Neurociencias (Biológicas) 2403 Bioquímica 2407 Biología Celular 2490 Neurociencias |
| topic |
615.9 591.18 612.8 Cannabinoid CB1 receptor Oligodendrogenesis Myelination Bioquímica (Biología) Biología molecular (Biología) Neurociencias (Biológicas) 2403 Bioquímica 2407 Biología Celular 2490 Neurociencias |
| description |
Cannabinoids are known to modulate oligodendrogenesis and developmental CNS myelination. However, the cell-autonomous action of these compounds on oligodendroglial cells in vivo, and the molecular mechanisms underlying these effects have not yet been studied. Here, by using oligodendroglial precursor cell (OPC)-targeted genetic mouse models, we show that cannabinoid CB1 receptors exert an essential role in modulating OPC differentiation at the critical periods of postnatal myelination. We found that selective genetic inactivation of CB1 receptors in OPCs in vivo perturbs oligodendrogenesis and postnatal myelination by altering the RhoA/ROCK signaling pathway, leading to hypomyelination, and motor and cognitive alterations in young adult mice. Conversely, pharmacological CB1 receptor activation, by inducing E3 ubiquitin ligase-dependent RhoA proteasomal degradation, promotes oligodendrocyte development and CNS myelination in OPCs, an effect that was not evident in OPC-specific CB1 receptordeficient mice. Moreover, pharmacological inactivation of ROCK in vivo overcomes the defects in oligodendrogenesis and CNS myelination, and behavioral alterations found in OPC-specific CB1 receptor-deficient mice. Overall, this study supports a cellautonomous role for CB1 receptors in modulating oligodendrogenesis in vivo, which may have a profound impact on the scientific knowledge and therapeutic manipulation of CNS myelination by cannabinoids. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2022-01-01 2022 2022-01-01 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/20.500.14352/88941 |
| url |
https://hdl.handle.net/20.500.14352/88941 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Springer Nature |
| publisher.none.fl_str_mv |
Springer Nature |
| dc.source.none.fl_str_mv |
reponame:Docta Complutense instname:Universidad Complutense de Madrid (UCM) |
| instname_str |
Universidad Complutense de Madrid (UCM) |
| reponame_str |
Docta Complutense |
| collection |
Docta Complutense |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869417227598430208 |
| score |
15,301629 |